公司資料
ANI Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- ANIP
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
76.00 USD (-0.71%)
收盤價
最後更新: 2026年8月17日
1.7B USD
市值
股價為何變動
As of Aug 17, 2026, ANIP closed down 0.71% at $76.00. No new same-company headline was identified in the current news window.
公司概覽
Rare-Disease and Specialty Pharmaceuticals
ANI Pharmaceuticals develops and commercializes medicines across rare disease, ophthalmology and established pharmaceutical markets. Its model combines branded specialty products with a portfolio of generic medicines.
Cortrophin Gel
Purified Cortrophin Gel is an adrenocorticotropic hormone therapy used across selected autoimmune and inflammatory indications. It is the primary growth driver of ANI's rare-disease franchise.
Ophthalmology Portfolio
ILUVIEN and YUTIQ are sustained-release fluocinolone implants for retinal diseases, including diabetic macular edema and chronic noninfectious uveitis affecting the posterior segment.
未來催化劑
- Phase 4 SYNCHRONICITY results in noninfectious uveitis at a medical conference in the third quarter of 2026.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。